Duration Impact on Onset — PK/PD Geometry

Onset Geometry — Rising-Phase Interpretation

Dissolution and gastrointestinal availability establish the material entering the absorption process, after which absorption rate determines the speed and shape of systemic input. A faster input process produces a steeper rising concentration phase, while a slower input process spreads concentration formation over a broader time interval. The resulting slope, curvature, and early exposure accumulation determine how the trajectory approaches a modeled PD threshold region. This makes absorption geometry a primary component of onset interpretation, because threshold-region entry depends on where the rising trajectory intersects the defined PD mapping. Duration is not created by the rising phase alone; it emerges from how the trajectory subsequently distributes, turns over, and declines. Consequently, two profiles can have similar threshold-entry times while occupying different later persistence regions, or different entry times while sharing similar persistence geometry. Absorption rate therefore describes early trajectory formation rather than duration itself. See absorption rate.

Distribution and metabolism can alter the rising-phase trajectory after systemic input begins. Distribution kinetics determine how rapidly concentration moves among modeled compartments, which can change the early plasma concentration shape and the relationship between input and observed exposure. Metabolic turnover simultaneously removes drug from the central trajectory, influencing the balance between incoming and disappearing material. If distribution is rapid relative to input, early concentration can be reshaped before threshold-region entry; if distribution is slower, compartmental movement can broaden or delay the central exposure profile. Metabolic turnover can similarly reduce the height or steepness of the rising phase when elimination begins to offset absorption. These mechanisms do not create a separate onset variable; they modify the concentration trajectory that is mapped onto the PD threshold. Modeled onset therefore reflects the combined geometry of absorption, distribution, and metabolism rather than any single parameter. See pkpd onset drivers.

Duration Geometry — Persistence Interpretation

Persistence is determined by the behavior of the concentration trajectory after its initial rise, with distribution, metabolic turnover, and elimination rate controlling how exposure moves through the descending portion. Distribution can create secondary compartmental movement that sustains or reshapes central concentrations, while metabolic turnover determines the rate at which drug is transformed. Elimination then governs the net decline after systemic input decreases, although these processes can overlap rather than occur as isolated stages. A slower net decline produces a broader persistence region, whereas a faster decline compresses that region. This persistence geometry is distinct from onset geometry: onset depends on the rising trajectory reaching a modeled PD region, while duration depends on continued occupancy of that region during the later trajectory. PK variability can shift any of these parameters, producing different persistence shapes without requiring a corresponding change in the conceptual definition of onset. Thus, duration is a property of the full trajectory, not a direct substitute for onset timing. See pk variability.

Tadalafil can be represented by a parameter set that produces substantially longer concentration persistence than the shorter-persistence profile commonly associated with sildenafil. Mechanistically, this distinction belongs mainly to the later trajectory: slower net decline allows concentration to occupy a persistence region for a longer modeled interval after the rising phase has reached its relevant threshold region. The longer persistence can therefore make threshold entry appear geometrically embedded within a broad exposure trajectory, whereas a faster-declining profile can place the same entry nearer to the later boundary of its persistence region. This does not mean that persistence determines the initial threshold crossing. The rising phase remains governed by absorption, systemic input, distribution, and metabolic balance, while the later phase reflects distributional redistribution and elimination processes. Tadalafil’s longer duration geometry consequently provides a different temporal context for onset interpretation without changing the underlying definition of threshold-region entry. See why tadalafil lasts longer.

PK→PD Balance — Duration Influence on Onset Interpretation

A PK trajectory contains distinct but connected geometric regions: an input and rising region, a peak region, and a declining persistence region. Onset is mapped to the point where the rising trajectory enters a defined PD-relevant region, whereas duration is mapped to the subsequent interval over which the trajectory remains within that region. Speed profiles can therefore differ in both threshold-entry timing and persistence width without requiring one variable to define the other. A relatively rapid rising phase can reach the modeled threshold sooner, while a slower decline can extend the later persistence region. Conversely, a similar rising phase followed by faster elimination produces a narrower persistence region. The full trajectory is useful because it shows how early entry relates spatially and temporally to the later boundary. Duration influences interpretation by supplying that context, not by moving the original rising-phase mechanics. PK geometry therefore separates the timing of entry from the width of subsequent persistence. See speed profiles.

PD mapping supplies the response-side geometry that converts concentration into defined threshold regions. A modeled onset boundary specifies where the rising concentration trajectory enters a relevant PD region, while a persistence boundary specifies where concentration remains sufficiently associated with that region during the later trajectory. Changes in PD sensitivity, coupling, or threshold placement can shift these boundaries even when PK parameters remain constant. As a result, the same sildenafil or tadalafil concentration–time curve can have different modeled threshold-entry and persistence timings under different PD parameter sets. The key distinction is that PK determines the path through concentration space, while PD mapping determines which parts of that path are classified as entry or persistence regions. Onset–duration interpretation therefore depends on both trajectory geometry and threshold placement. The later persistence profile can provide temporal context for the earlier crossing, but it does not retroactively alter the PK mechanisms that generated that crossing. See onset difference.

Duration can modify the interpretation of onset by defining where the threshold-entry point sits within the complete PK→PD trajectory. If persistence is short, the interval between threshold-region entry and the later persistence boundary is geometrically compact. If persistence is long, that interval is broader, so the same type of early threshold entry occupies a different position relative to the trajectory’s endpoint. This distinction is especially useful when comparing parameter sets such as a shorter-persistence sildenafil profile with a longer-persistence tadalafil profile. The comparison concerns the geometry of entry, peak, decline, and persistence rather than subjective experience or clinical effect. Importantly, duration does not shift an onset crossing merely because the later decline is longer or shorter. Any change in threshold-entry timing must arise from parameters affecting the rising trajectory or PD mapping. Duration instead changes the temporal context in which that crossing is interpreted within the full modeled profile. See duration vs onset balance.